Reducing Subject Dropout Rates
Apex is at the forefront of investigating strategies to enhance participant retention in clinical trials.
Lessons Gained from Attention-Deficit/Hyperactivity and Anxiety Disorders Clinical Trial Methodologies
Strategies for Improving Retention Within These Trials
Cultivating Retention in Schizophrenia and Schizoaffective Disorder Studies
Patient Preferences for Clinical Trial Methodologies and COVID-19 Mitigations
Key Factors For Participant Retention
Research sites’ study data and strategies for preventing attrition in depression trials
Furthering Our Understanding Of Participant Retention
An analysis of research sites’ study data and methodological correlates
Attending To The Patient With Major Depression
Preferences for clinical trial methodologies and COVID-19 mitigations
Giving Voice To Patients With Schizophrenia Or Schizoaffective Disorder
Preferences for clinical trial methodologies and COVID-19 mitigations
Preferences of the Opioid Use Disorder Patient
Clinical Trial Methodologies and COVID-19 Mitigations that Motivate Participation
